Profit taking weighed down shares of Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG) $1.17 to close at $2.53.
Profit taking weighs down Eyegate Pharmaceuticals
February 22, 2017 at 17:00 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.